Perceptive Pharma Research | Richmond, TX
Status and phase
Conditions
Treatments
About
The purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Alto Neuroscience
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal